Otaplimastat - Shin Poong Pharmaceutical
Alternative Names: SP-8203; SP-8203 hydrochloride; SP8203HCLLatest Information Update: 24 Oct 2021
At a glance
- Originator Shin Poong Pharmaceutical
- Class Amides; Amines; Neuroprotectants; Quinazolines; Small molecules
- Mechanism of Action Reactive oxygen species inhibitors; Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Stroke
Most Recent Events
- 19 Oct 2020 Shin Poong Pharmaceutical completes a phase IIb trial for Stroke (Adjuvant treatment) in South Korea (NCT04479449)
- 01 May 2016 Phase-II clinical trials in Stroke (Adjunctive treatment) in South Korea (IV) (NCT02787278)
- 11 Mar 2015 Shin Poong Pharmaceutical completes a phase I trial in Healthy volunteers in South Korea (NCT01757795)